Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery

Clinical Trial Details

The purpose of this clinical study is to collect data from patients to evaluate the safety and effectiveness of the AtriCure CryoICE Cryoablation System for the treatment of persistent and long-standing persistent atrial fibrillation during open-heart surgery. 

Key Eligibility: 
  • Open to men and women above the age of 18 who have been diagnosed with a non-paroxysmal form of atrial fibrillation (persistent or longstanding persistent)
  • Participants must be scheduled for a planned open-heart procedure 
  • Detailed eligibility will be reviewed when you contact the study team
Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Nathan Palaparthi
212-746-5194
ntp2001@med.cornell.edu

Primary Investigator(s)

Leonard N Girardi, MD  (UES)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1904020049

ClinicalTrials.gov:

NCT03732794

Status

Open to Enrollment

Age Group

Adult

Sponsor

  • AtriCure

Disease

Cardiovascular/Heart
Atrial Fibrillations